期刊文献+

胱抑素C在糖尿病中的应用研究进展 被引量:5

Cystatin C in Diabetes Research Progress
下载PDF
导出
摘要 既往研究表明,胱抑素C抑制半胱氨酸蛋白酶活性,可以反应肾小球受损。新近研究发现,胱抑素C可能受到年龄、性别的影响。它可能预测早期糖尿病的发生,是比肌酐更为敏感的评价肾功能损害的指标。此外还参与炎症过程,与动脉粥样硬化的发生、发展有关,与冠状动脉、外周动脉病变有良好的相关性,可以预测糖尿病心血管并发症的风险,如预测急性冠状动脉综合征的发生和预后,预测冠状动脉病变的广度及心力衰竭的风险,在糖尿病领域有广泛用途。 Previously research indicated that cystatin C inhibitory the activity of cysteine protease. It can respond to glomerular damage. Recent study found that cystatin C may be subject to age,gender impact. It is possible to predict the early occurrence of diabetes. It is more sensitive than creatinine for evaluation of the indicators of renal dysfunction. In addition cystatin C is also involved in the inflammation process ,related with the occurrence and development of atherosclerosis. Between cystatin C and the coronary artery, peripheral arterial disease,there is a good relationship. We can predict the risk of cardiovascular complications of diabetes,such as the occurrence and prognosis of acute coronary syndrome,the extent of coronary artery disease,the risk of heart failure. Cystatin C have a wide range of uses in the field of diabetes.
作者 陆新虹
出处 《医学综述》 2009年第19期2997-2999,共3页 Medical Recapitulate
关键词 胱抑素C 糖尿病肾病 动脉粥样硬化 冠状动脉硬化性心脏病 外周动脉病变 Cystatin C Diabetic nephropathy Atherosclerosis Coronary arteriosclerotic heart disease Periphery arterial disease
  • 相关文献

参考文献22

  • 1任爱英,王凡.血清胱抑素C的临床应用及研究[J].检验医学与临床,2008,5(1):32-34. 被引量:45
  • 2K(o)ttgen A,Selvin E,Stevens LA,et al,Serum cystatin C in the United States:the Third National Health and Nutrition Examination Survey (NHANES Ⅲ)[J].Am J Kidney Dis,2008,51 (3):385-394.
  • 3Stevens LA,Schmid CH,Greene T,et al,Factors other than glomerular filtration rate affect serum cystatin C levels[J].Kidney Int,2009,75 (6):652-660.
  • 4Donahue RP,Stranges S,Rejman K,et al,Elevated cystatin C concentratian and progression to pre-diabetes:The Western New York Study[J].Diabetes Care,2007,30 (7):1724-1729.
  • 5Chudleigh RA,Ollerton RL,Dunseath G,et al,Use of cystatin Cbased estimations of glomerular filtration rate in patients with type 2 diabetes[J].Diabetolngia,2009,52 (7):1274-1278.
  • 6Shlipak MG,Katz R,Kestenbaum B,et al,Rate of kidney function decline in older adults:a comparison using creatinine and cystatin C[J].Am J Nephrol,2009,30(3):171-178.
  • 7McNamara NV,Chen R,Janu MR,et al,Early renal failure detection by cystatin C in type 2 diabetes mellitus:varying patterns of renal analyte expression[J].Pathology,2009,41 (3):269-275.
  • 8Rigalleau V,Beauvieux MC,Le Moigne F,et al,Cystatin C improves the diagnosis and stratification of chronic kidney disease,and the estimation of glomerular filtration rate in diabetes[J].Diabetes Metab,2008,34 (5):482-489.
  • 9Premaratne E,Maclsaac RJ,Fineh S,et al,Serial rneasurements of cystatin C are more accurate than creatinine-based methods in detecting declining renal function in type 1 diabetes[J].Diabetes Care,2008,31 (5):971-973.
  • 10Rosolowsky ET,Niewczas MA,Ficociello LH,et al,Between hyperfiltration and impairment:demystifying early renal functional changes in diabetic nephropathy[J].Diabetes Res Clin Pract,2008,13(82 Suppl 1):S46-S53.

二级参考文献22

  • 1[1]Anderson JK,Schmidt C,Nordin G,et al.determined by a rapid,automated particle-enhanced turbidi metric method,is a batter marker than serum creatinine for glomerular filtration rate[J].Clin Chem,1994,40(10):1921-1926.
  • 2[2]Finney H,Newman DJ,Gruber W.Initial evaluation of cystatin c measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems(BNA,BN11)[J].Clin Chem,1997,43(6):1016-1020.
  • 3[3]Randers E,Erlanden EJ.Serum Cystatin C as an endogenous marker of the renal function ; a review[J].Clin Chem Labmed,1999,37(4):389-395.
  • 4[5]Pergande M,Jung K.Sandwich enzy me immunoassay of Cystatin C in serum with commercially available antibodies[J].Chin Chem,1993,39(9):1885-1990.
  • 5[6]Randers E,Erlandsen EJ,Pederson QL.Serum Cystatin C as an endogenous parameter of renal function in patients with normal to moderately impaired kidney function[J].Chin Nephrol,2000,54(3):203-209.
  • 6Lindholt JS, Erlandsen E J, Henneberg EW. Cystatin C deficiency is associated with the progression of small abdominal aortic aneurysms [ J ]. Br J Surg, 2001, 88 : 1472-1475.
  • 7Sukhova GK, Wang B, Libby P, et al. Cystatin C deficiency increases elastic lamina degradation and aortic dilatation in apolipoprotein E-nun mice[ J]. Circ Res, 2005,96 : 368 -375.
  • 8Yetkin E, Acikgoz N, Sivri N, et al, Increased plasma levels of cystatin C and transforming growth factor-betal in patients with coronary artery, ectasia: can there be a potential interaction between cystatin C and transforming growth factor-betal [ J ]. Coron Artery Dis ,2007,18 ( 3 ) :211-214.
  • 9Noto D,Cefalu'AB,Barbagallo CM,et al. Cystatin C levels are decreased in acute myocardial infarction:effect of cystatin C G73A gene polymorphism on plasma levels[J]. Int J Cardiol,2005,101(2) :213-217.
  • 10Luc G, Bard JM, Lesueur C. et al. Plasma cystatin-C and development of coronary heart disease : The PRIME Study [ J ]. Atheroselerosis, 2006,85 ( 2 ) : 375- 380.

共引文献79

同被引文献72

  • 1杜桂芹,程欣弘,常曼丽,王秀云.下肢静脉曲张患者的血流变及血脂分析[J].中国血液流变学杂志,2004,14(2):263-264. 被引量:5
  • 2向礼贤.血清胱抑素C检测与疾病[J].四川医学,2004,25(11):1258-1259. 被引量:31
  • 3Laterza OF,Price CP,Scott MG.Cystatin C:an improved estimator of glomerular filtration rate? Clin Chem.2002;48:699-707.
  • 4Brown TM,Bittner V.Biomarkers of atherosclerosis:clinical applications.Curr Cardiol Rep.2008;10(6):497-504.
  • 5Shlipak MG,Katz R,Kestenbaum B,et al.Clinical and subclinical cardiovascular disease and kidney function decline in the elderly.Atherosclerosis.2009;204(1):298-303.
  • 6Bengtsson E,Nilsson J,Jovinge S.Cystatin C and cathepsins in cardiovascular disease.Front Biosci.2008; 13:5780-5786.
  • 7Deo R,Fyr CL,Fried LF,et al.Kidney dysfunction and fatal cardiovascular disease-an association independent of atherosclerotic events:results from the Health,Aging,and Body Composition (Health ABC)study.Am Heart J.2008;155(1):62-68.
  • 8Djousse L,Kurth T,Gaziano JM.Cystatin C and risk of heart failure in the physicians' health study.Am Heart J.2008;155(1):82 -86.
  • 9Lassus J,Harjola VP,Sund R,et al.Prognostic value of cystatin C in acute heart failure in relation to other markers of renal function and NT-proBNP.Eur Heart J.2007;28(15):1841-1847.
  • 10Gupta S,Drazner MH,de Lemos JA.Newer biomarkers in heart failure.Heart Fail Clin.2009;5(4):579-588.

引证文献5

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部